# Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

> **NCT00145353** · PHASE4 · UNKNOWN · sponsor: **Odense University Hospital** · enrollment: 16 (—)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin NovoRapid versus Actrapid

## Key facts

- **NCT ID:** NCT00145353
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 16 (—)
- **Last updated:** 2006-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145353, "Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00145353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*